Bristol Myers Squibb Myeloma Trials
Hi, we're SparkCures. We've partnered with Bristol Myers Squibb to help healthcare professionals find and connect with myeloma clinical trials from around the US.
Featured Clinical Trials
Learn more about the Successor-1 trial for patients with relapsed/refractory multiple myeloma who have received 1-3 prior lines of therapy.
Learn more about the Successor-2 trial for patients with relapsed/refractory multiple myeloma who have received one prior line of therapy.
Quickly Find Eligible Clinical Trials
Use our quick screen buttons below to find eligible BMS clinical trials wherever your patients may be.
Newly DiagnosedMyeloma patients who are untreated / newly diagnosed.
1-2 Prior LinesMyeloma patients with 1 to 2 prior lines of therapy.
3+ Prior LinesMyeloma patients with 3 or more lines of therapy.
3+ Lines (BCMA)Myeloma patients with 3 or more lines of therapy and BCMA therapy
CELMoD TrialsView all CELMoD clinical trials from around the US
View All TrialsView all myeloma trials sponsored by BMS
At SparkCures we help myeloma patients and healthcare professionals find, understand and connect with eligible clinical trials from around the US.
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.